3.0
Feb 20, 2026
Recommend
CEO approval
Business Outlook
Pros
Exposure to pharmaceutical CDMO culture.
Cons
They were lacking fundamentally in direction and science. They very much had a crunch culture that kept their difficulties hidden instead of addressing them.